Catalyst Wire Dossier Catalyst Wire Dossier

Disulfiram-Copper gluconate

disulfiram-copper gluconate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Disulfiram-Copper gluconate, covering 2023-10-18 to 2023-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine [Phase 2]

See pricing